Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
The report details the trend, potential and market size of Anti-tumor Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-tumor Drugmarket, defines the market attractiveness level of Anti-tumor Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-tumor Drug industry, describes the types of Anti-tumor Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-tumor Drug market and the development prospects and opportunities of Anti-tumor Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-tumor Drug market in Chapter 13.
By Player:
Novartis
Roche
Celgene
By Type:
Surgical
Chemotherapy
Radiation
Targeted
Immunotherapy
By End-User:
Hospital Use
Clinic Use
Household
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-tumor Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-tumor Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-tumor Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-tumor Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-tumor Drug Market Analysis and Outlook to 2022
-
7.1 Global Anti-tumor Drug Consumption (2017-2022)
-
7.2 United States Anti-tumor Drug Consumption (2017-2022)
-
7.3 Europe Anti-tumor Drug Consumption (2017-2022)
-
7.4 China Anti-tumor Drug Consumption (2017-2022)
-
7.5 Japan Anti-tumor Drug Consumption (2017-2022)
-
7.6 India Anti-tumor Drug Consumption (2017-2022)
-
7.7 South Korea Anti-tumor Drug Consumption (2017-2022)
8 Region and Country-wise Anti-tumor Drug Market Analysis and Outlook to 2028
-
8.1 Global Anti-tumor Drug Consumption Forecast (2022-2028)
-
8.2 United States Anti-tumor Drug Consumption Forecast (2022-2028)
-
8.3 Europe Anti-tumor Drug Consumption Forecast (2022-2028)
-
8.4 China Anti-tumor Drug Consumption Forecast (2022-2028)
-
8.5 Japan Anti-tumor Drug Consumption Forecast (2022-2028)
-
8.6 India Anti-tumor Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-tumor Drug Consumption Forecast (2022-2028)
9 Global Anti-tumor Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-tumor Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Surgical Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Radiation Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Targeted Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-tumor Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Use Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Use Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Household Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Anti-tumor Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-tumor Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Surgical Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Radiation Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Targeted Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-tumor Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Use Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Household Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-tumor Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-tumor Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-tumor Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-tumor Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-tumor Drug Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Anti-tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Anti-tumor Drug Product and Service
-
14.2 Roche
-
14.2.1 Roche Company Details
-
14.2.2 Roche Anti-tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Roche Anti-tumor Drug Product and Service
-
14.3 Celgene
-
14.3.1 Celgene Company Details
-
14.3.2 Celgene Anti-tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celgene Anti-tumor Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-tumor Drug
-
Figure Anti-tumor Drug Picture
-
Table Global Anti-tumor Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-tumor Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-tumor Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-tumor Drug Consumption by Country (2017-2022)
-
Figure United States Anti-tumor Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure China Anti-tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure India Anti-tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-tumor Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgical Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Use Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Use Consumption and Growth Rate (2017-2022)
-
Figure Global Household Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Surgical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Household Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-tumor Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-tumor Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Anti-tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Anti-tumor Drug Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Anti-tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Anti-tumor Drug Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Anti-tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Anti-tumor Drug Product and Service
-
